Similar articles

• A controlled study of luteinizing hormone-releasing hormone agonist (buserelin) for the induction of folliculogenesis before in vitro fertilization.

  MacLachlan V, Besanko M, O'Shea F, Wade H, Wood C, Trounson A, Healy DL. MacLachlan V, et al. N Engl J Med. 1989 May 11;320(19):1233-7. doi: 10.1056/NEJM198905113201902. N Engl J Med. 1989. PMID: 2496310 Clinical Trial.
• A controlled study of gonadotropin-releasing hormone agonist (buserelin acetate) for folliculogenesis in routine in vitro fertilization patients.

  Polson DW, MacLachlan V, Krapez JA, Wood C, Healy DL. Polson DW, et al. Fertil Steril. 1991 Sep;56(3):509-14. doi: 10.1016/s0015-0282(16)54550-6. Fertil Steril. 1991. PMID: 1909978 Clinical Trial.
• Gonadotropin-releasing hormone antagonist versus agonist administration in women undergoing controlled ovarian hyperstimulation: cycle performance and in vitro steroidogenesis of granulosa-lutein cells.

  Minaretzis D, Alper MM, Oskowitz SP, Lobel SM, Mortola JF, Pavlou SN. Minaretzis D, et al. Am J Obstet Gynecol. 1995 May;172(5):1518-25. doi: 10.1016/0002-9378(95)90490-5. Am J Obstet Gynecol. 1995. PMID: 7755066
• Randomized trial of three luteinizing hormone-releasing hormone analogues used for ovarian stimulation in an in vitro fertilization program.

  Parinaud J, Oustry P, Perineau M, Rème JM, Monroziès X, Pontonnier G. Parinaud J, et al. Fertil Steril. 1992 Jun;57(6):1265-8. doi: 10.1016/s0015-0282(16)55085-7. Fertil Steril. 1992. PMID: 1534774 Clinical Trial.
• Effects of the menstrual cycle on medical disorders.

  Case AM, Reid RL. Case AM, et al. Arch Intern Med. 1998 Jul 13;158(13):1405-12. doi: 10.1001/archinte.158.13.1405. Arch Intern Med. 1998. PMID: 9665348 Review.